Provided by Tiger Fintech (Singapore) Pte. Ltd.

LISATA THERAPEUTICS INC

2.22
+0.01000.45%
Volume:5.55K
Turnover:12.16K
Market Cap:18.67M
PE:-0.97
High:2.24
Open:2.13
Low:2.13
Close:2.21
Loading ...

Lisata Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
09 May

Lisata Therapeutics Q1 EPS $(0.55) Misses $(0.53) Estimate

Benzinga
·
09 May

Lisata Therapeutics Inc: Cash Runway Extending Into Q3 of 2026 With No Debt

THOMSON REUTERS
·
09 May

Lisata Therapeutics Inc expected to post a loss of 53 cents a share - Earnings Preview

Reuters
·
07 May

Lisata Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update on Thursday, May 8, 2025

THOMSON REUTERS
·
01 May

Lisata Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update on Thursday, May 8, 2025

GlobeNewswire
·
01 May

Will Lisata Therapeutics (NASDAQ:LSTA) Spend Its Cash Wisely?

Simply Wall St.
·
26 Apr

BRIEF-Lisata Therapeutics- Will Evaluate Efficacy Of Certepetide

Reuters
·
15 Apr

Lisata Therapeutics- Will Evaluate Efficacy of Certepetide, as Payload in Context of Catalent's Smartag ADC Dual-Payload Technology Platform

THOMSON REUTERS
·
15 Apr

Lisata Therapeutics Announces Research License with Catalent

GlobeNewswire
·
15 Apr

Press Release: Bladex and Scotiabank lead US$100 million loan for EGE Haina

Dow Jones
·
14 Mar

Lisata Therapeutics Inc (LSTA) Q4 2024 Earnings Call Highlights: Promising Developments Amid ...

GuruFocus.com
·
28 Feb

Lisata Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Feb

Lisata Therapeutics Inc: Cash Runway Extending Into Q2 of 2026 With No Debt

THOMSON REUTERS
·
28 Feb

Lisata Therapeutics Inc expected to post a loss of 76 cents a share - Earnings Preview

Reuters
·
26 Feb

BTN's Sustainable Finance Framework Receives Excellent Rating from Sustainable Fitch

Tempo
·
23 Feb

Lisata Therapeutics and Warpnine Announce Encouraging Preliminary Results From the Phase 1B/2a Ilsta Trial Evaluating Certepetide in Locally Advanced Non-Resectable Pancreatic Ductal Adenocarcinoma

THOMSON REUTERS
·
23 Jan

Lisata Therapeutics Shares Tumble After Pancreatic Cancer Treatment Results

Dow Jones
·
23 Jan

US Stocks Higher; Netflix Profit Beats Estimates

Benzinga
·
22 Jan

Lisata Therapeutics reports preliminary Cohort A data from Phase 2 ASCEND trial

TIPRANKS
·
22 Jan